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Abstract
Environmental factors can change phenotypes in exposed individu-
als and offspring and involve the germline, likely via biological
signals in the periphery that communicate with germ cells. Here,
using a mouse model of paternal exposure to traumatic stress, we
identify circulating factors involving peroxisome proliferator-
activated receptor (PPAR) pathways in the effects of exposure to
the germline. We show that exposure alters metabolic functions
and pathways, particularly lipid-derived metabolites, in exposed
fathers and their offspring. We collected data in a human
cohort exposed to childhood trauma and observed similar meta-
bolic alterations in circulation, suggesting conserved effects.
Chronic injection of serum from trauma-exposed males into
controls recapitulates metabolic phenotypes in the offspring. We
identify lipid-activated nuclear receptors PPARs as potential
mediators of the effects from father to offspring. Pharmacologi-
cal PPAR activation in vivo reproduces metabolic dysfunctions in
the offspring and grand-offspring of injected males and affects
the sperm transcriptome in fathers and sons. In germ-like cells
in vitro, both serum and PPAR agonist induce PPAR activation.
Together, these results highlight the role of circulating factors
as potential communication vectors between the periphery and
the germline.
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Introduction
Environmental factors and life events can have long-lasting conse-
quences for exposed individuals, and in some cases, they can also
impact their offspring. Transmission of environmentally induced
features and diseases has been overlooked for decades. But today,
evidence that diet, traumatic experiences or endocrine disruptors
have effects across generations has accumulated in humans and
experimental animals (Bohacek & Mansuy, 2015; Nilsson et al, 2018;
Panzeri & Pospisilik, 2018). These effects are known to depend on
epigenetic factors and constitute an important aetiological compo-
nent of many diseases. When transmitted from parent to progeny
and not depending on maternal care or social factors, they are
thought to involve the germline. They therefore represent a form of
heredity. But how exposure can affect the germline and which
signals induced by exposure in the body can reach germ cells is not
known. These signals may vary depending on the type of exposure,
its time window, chronicity, etc. They have in common the ability to
reach germ cells. Circulating factors are important vectors of
communication between tissues and cells across the body. We postu-
late that they can carry signals induced by exposure to germ cells
and contribute to the transmission of the effects of exposure to the
progeny. Blood metabolites in particular are strong candidates for
being such carriers because many are potent signalling molecules,
e.g. hormones, lipids, organic acids and antioxidants. Further, they
are dynamically regulated by physiological states in mammals.
Several metabolites have been previously implicated in the epige-
netic regulation of the genome in different tissues (Donohoe & Bult-
man, 2012; Kaelin et al, 2013; Sharma & Rando, 2017).
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Results
Blood metabolites are altered in mice exposed to early
life trauma
We examined the contribution of circulating metabolites to the
effects of exposure from exposed individuals to their offspring. We
used an established mouse model of early postnatal trauma based
on unpredictable maternal separation combined with unpredictable
maternal stress (MSUS) (Fig 1A and B). Mice exposed to MSUS have
metabolic dysfunctions and behavioural deficits that are transmitted
to the offspring across several generations (Franklin et al, 2010;
Gapp et al, 2014b, 2016b; van Steenwyk et al, 2018). We conducted
unbiased metabolomic analyses in exposed adult males and their
offspring using time-of-flight mass spectrometry (TOF-MS). The
analyses showed that polyunsaturated fatty acid (PUFA) metabo-
lism, in particular, metabolites involved in a-linolenic/linoleic acid
(ALA/LA), and arachidonic acid (AA) pathways are significantly
upregulated by MSUS in plasma of adult males (Fig 1C). PUFAs,
such as eicosapentaenoic acid (EPA) and dihomo-gamma-linoleic
acid (DGLA), and arachidonic metabolites, such as the hydroxye-
icosatetraenoic acids (HETEs), were the most significantly upregu-
lated within the enrichments (Fig 1D). In addition, bile acid
biosynthesis as well as steroidogenesis and the steroidogenic ligand
aldosterone were downregulated (Fig 1C, full table in Appendix Figs
S1 and S2). Altered steroidogenesis is consistent with previous
observation in the MSUS model that the steroid mineralocorticoid
receptor (MR) is downregulated. Its pharmacological blockade
mimics some MSUS effects (Gapp et al, 2014b). Remarkably, except
for AA metabolism, these pathways were also altered in the
offspring of MSUS males when adult (Fig 1C, Appendix Fig S1). We
focused the analyses on male offspring since bodyweight is signifi-
cantly affected in male but not female offspring (Appendix Fig S3).
Blood metabolites are altered in children exposed to early
life trauma
We assessed the relevance of these results in humans by conducting
similar analyses in a cohort of children (6- to 12-year-old girls and
boys) from an SOS Children’s Village in Lahore, Pakistan. The chil-
dren have lost their father and were separated from their mother
(paternal loss and maternal separation, PLMS) during the preceding
year (Fig 1A). These conditions closely resemble the MSUS model.
This human cohort is highly relevant for our study because SOS
children have been exposed to a comparable trauma at a compara-
ble age, which is key for correlative analyses with our mouse data.
All SOS children live in the same orphanage, so differences in life-
style factors are minimal. Control children were schoolmates living
with both parents and not exposed to any trauma. PLMS and control
groups were matched for age, body mass index and gender
(Appendix Fig S4A–C). Control and PLMS groups attended the same
school, with equal access to playground facilities and physical exer-
cise. A Pakistani population was advantageous for this study
because consanguinity is high in Pakistan (Bittles et al, 1991)
(Appendix Fig S4D), making the group genetically more homoge-
neous than in other populations. Body mass index, diet and ethnic-
ity account for < 5% of the variance between serum metabolites in
healthy children from 6 different European populations (Lau et al,
2018), suggesting that our control samples are indeed comparable to
other populations. Blood and saliva were collected from PLMS and
control children. For these analyses and the following ones in
humans, we used serum over plasma to avoid interference with clot-
ting factors. Serum metabolites had significantly positive enrich-
ment for AA metabolism and modest negative enrichment for bile
acid biosynthesis compared to controls, with EPA, DGLA and HETEs
being strongly affected (Fig 1C and D) similarly to MSUS. In saliva,
both ALA/LA and AA metabolism, and steroidogenesis were also
altered (Fig 1C, Appendix Fig S5), indicating alterations in different
body fluids. Among the enrichments, individual metabolites in
ALA/LA and AA pathways were comparably affected in MSUS and
PLMS serum (Appendix Fig S6).
PPAR is activated by MSUS blood metabolites
While we consider all circulating factors altered by MSUS to be
potentially involved in germline transmission, we focused on the
changes in fatty acids, especially PUFA, and their metabolites.
PUFAs are known to modulate metabolism, inflammation and
cognitive functions. Fatty acids and their metabolites can bind to
various receptors, but are particularly potent ligands for peroxisome
proliferator-activated receptors (PPARs). PPARs are widely
expressed nuclear receptors that regulate gene expression and chro-
matin structure, and act by forming transcription factor complexes
with retinoid X receptor (RXR). They can also interact with epige-
netic modifying enzymes (Yu & Reddy, 2007; Romagnolo et al,
2014). Further to fatty acids, bile acids and steroid metabolites, also
altered by MSUS, are ligands for nuclear receptors, in particular,
farsenoid X receptor (FXR) and liver X receptor (LXR). FXR and LXR
belong to the same family of nuclear receptors as PPAR and RXR,
and can interact with them (Chawla et al, 2001).
Since PUFAs are PPAR ligands, we next examined if changes in
circulating factors in MSUS males are linked to PPAR activity. We
examined the expression of PPAR and some of their target genes in
different tissues. In white adipose tissue, PPARc is abundant and
regulates adipocyte differentiation (Lee & Ge, 2014). PPARc activa-
tion measured by transcription factor binding assay was increased
in adult MSUS adipose tissue (Appendix Fig S7A). In liver, a tissue
with high PPARa activity (Rakhshandehroo et al, 2010), several
PPAR targets were differentially expressed, suggesting PPARa acti-
vation (Appendix Fig S7B). Further, because metabolic symptoms
induced by MSUS are passed to the offspring, we also examined if
germ cells have altered PPAR. PPARc, the most abundant PPAR
isotype in gametes (Aquila et al, 2006), was upregulated in MSUS
sperm (Fig 2A). We then asked if metabolomic changes induced by
MSUS can influence PPAR activity in germ cells. We used spermato-
gonial stem cell-like cells (GC-1 spg), diploid cells that resemble
early-stage spermatogonial cells, to assess PPAR activity in vitro.
Spermatogonial cells were chosen because they are the primary
germ cells present in the developing testes at the time of MSUS (first
2 weeks after birth). GC-1 spg cells were exposed to culture medium
enriched with 10% serum from control or MSUS adult males
(Fig 2B). Prior to exposure, GC-1 spg cells were transfected with a
plasmid expressing luciferase under the control of a PPAR response
element (PPRE). Luciferase luminescence was significantly higher in
cells exposed to MSUS serum compared to control serum (Fig 2C),
indicating increased PPAR activation by MSUS serum.
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Figure 1. Effects of early life trauma on circulating metabolites in mice and humans.
A Paradigms of early life trauma in mice and humans. In mice, early life trauma consists of an exposure to unpredictable maternal separation combined with
unpredictable maternal stress (MSUS). In humans, exposure involves paternal loss and maternal separation (PLMS) in early childhood (age 6–12).
B Scheme illustrating the MSUS model and control mice showing blood collection and breeding to generate an offspring. For MSUS (symbolized by yellow blitz),
newborn pups are separated from their mother unpredictably 3 h/day from postnatal day (PND) 1–14. During separation, the dam is exposed to different stressors
unpredictably9. Serum was prepared from blood collected from 3-month-old MSUS and control males.
C Differential pathway enrichment of metabolites in MSUS plasma from adult males and their offspring compared to controls (each group n = 5), and serum (PLMS,
n = 20; control, n = 14) and saliva (PLMS, n = 25; control, n = 14) from PLMS and control children. Asterisk and hashtag represent FDR after multiple testing
corrections using Benjamini–Hochberg (BH) test. Columns indicate significance for positive (+) and negative () enrichment.
D Individual metabolites in ALA/LA and AA pathways significantly altered in both MSUS and PLMS. Numbers represent fold change according to a heat scale (right).
Data information: #FDR < 0.1, *FDR < 0.05, **FDR < 0.01, ***FDR < 0.001, ****FDR < 0.0001. (/) symbolizes non-significance. FDR, false discovery rate. ALA/LA, alpha-
linolenic acid/linoleic acid. AA, arachidonic acid. HETE, hydroxyeicosatetraenoic acid.
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Paternal PPAR activation induces phenotypes into offspring
and grand-offspring
Although previous studies have implicated PPAR and other
nuclear receptors in the effects of environmental exposure and
phenotype transmission (Lillycrop et al, 2008; Carone et al, 2010;
Zeybel et al, 2012; Martı́nez et al, 2014; Baptissart et al, 2018),
none have tested their causal involvement. We examined if PPAR
can induce phenotype transmission by mimicking its activation in
adult control males via chronic intraperitoneal (i.p.) injection of
the dual PPARa/c agonist tesaglitazar (10 lg/kg) (Fig 3A). We
chose a dual agonist to activate multiple PPAR and better mimic
the effects of MSUS. Following a 46-day delay after the last
injection to allow a full spermatogenesis cycle and eliminate tran-
sient effects of the drug, males were bred with control females to
generate offspring. When adult, the offspring were bred with
naı̈ve females to produce grand-offspring. Both offspring and
grand-offspring of tesaglitazar-injected males had significantly
reduced body weight compared to the offspring and grand-
offspring of vehicle-injected controls (Fig 3B; Appendix Fig S8A),
despite an initial increase at PND8 (Appendix Fig S9). This effect
was not due to a difference in fathers’ weight after the injections
or at the time of breeding (Appendix Fig S10). Further, blood
glucose during a glucose tolerance test (GTT) was reduced in
offspring and grand-offspring compared to controls (Fig 3C;




Figure 2. Analyses of PPAR expression and PPAR activity in sperm and germ-like GC-1 cells.
A PPARc mRNA expression in sperm from control and MSUS mice. Control, n = 15; MSUS, n = 13, two-tailed Student’s t-test, P = 0.029, t = 2.30, df = 26.
B Schematic of serum treatment of GC-1 cells. On day 1, cells are transfected with PPRE and luciferase normalization plasmids. Serum is mixed in culture medium at
10% concentration and exposed to cells on day 2. Cells are harvested 24 h later (Day 3), and luminescence is measured.
C Relative luciferase luminescence in transfected GC-1 cells exposed to serum from control or MSUS mice. Numbers correspond to serum from individual animals
applied to different cell culture wells. Control, n = 17; MSUS, n = 22, two-tailed Student’s t-test, P = 0.042, t = 2.1, df = 37.
Data information: Data are reported as mean  SEM.
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previously observed in MSUS offspring (Gapp et al, 2014a).
However, glucose response during a restraint stress was not
altered, unlike in MSUS animals (Gapp et al, 2014a; Appendix Fig
S11A). This may be because tesaglitazar does not involve the
stress response unlike MSUS. These results indicate that tesagli-
tazar can mimic some of the metabolic effects of MSUS across
generations.
We then asked if blockade of PPAR functions can have opposite
effects in the offspring. Because PPARc knockout models cannot
produce viable offspring (Barak et al, 1999; Kubota et al, 1999) and
lifelong alteration of PPAR activity strongly alters physiology
(Bensinger & Tontonoz, 2008), we used a PPARc antagonist
(T0070907), the most suitable existing drug we could identify.
T0070907 or saline was injected in adult control males, and the
injected males were bred to control females to obtain a progeny.
PPARc antagonist did not produce any effect on adult weight or
blood glucose on GTT in the offspring (Appendix Fig S12A and B),
suggesting that PPARc inhibition in adulthood is not sufficient to
affect metabolism or is effectively compensated for.
MSUS-induced shift in sperm payload is reflected in sperm of
tesaglitazar-injected fathers
Since sperm RNA has been causally involved in the transmission
of the effects of MSUS to the offspring (Gapp et al, 2014a, 2020),
we examined if RNA is altered in sperm of tesaglitazar-injected
A
B C
Figure 3. Tesaglitazar injection reproduces MSUS phenotypes in the offspring.
A Control males were injected with either tesaglitazar (grey syringe) or vehicle twice per week for 4 weeks. Males were paired with control females to generate
offspring.
B Adult weight in the offspring of tesaglitazar-injected males (Tesa-inj, n = 16) compared to the offspring of vehicle-injected males (Vehicle-inj, n = 23). Two-tailed
Student’s t-test, P = 0.019, t = 2.44, df = 37.
C Glucose level in the offspring of Tesa-inj (n = 14) and Vehicle-inj (n = 21) males during a glucose tolerance test. Repeated-measures ANOVA, treatment effect
P = 0.0083, F (1, 33) = 7.877, time effect P < 0.0001, F (4, 132) = 347.7, interaction P = 0.0776, F (4, 132) = 2.155 Conc.; concentration.
Data information: Data are reported as mean  SEM.
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males. Deep sequencing revealed differential RNA expression in
sperm of tesaglitazar-injected males compared to vehicle-injected
controls, in particular dysregulation of transposable elements (TEs)
(Appendix Fig S13A). These results are consistent with previous
observations in liver of tesaglitazar-treated mice (Ferguson et al,
2018) and in sperm of males exposed to MSUS (Gapp et al, 2020).
In a targeted analysis, 630 TE and > 4,000 mRNA/lincRNA tran-
scripts were annotated and there was a significant correlation in
fold change of differentially expressed TEs (MSUS versus controls
and tesaglitazar versus controls), including several long terminal
repeat elements (LTRs) between tesaglitazar-injected and MSUS
sperm (Fig 4A; Appendix Fig S13B). A modest fold change correla-
tion of mRNAs/lincRNAs was also noted, in particular with
lincRNAs that are the most enriched across datasets (Fig 4B;
Appendix Fig S13C). Several mRNAs were also altered in sperm of
tesaglitazar-injected males (FDR < 0.05), for instance, genes
involving the mitochondrial respiratory chain complex (Fig 4C and
D; Appendix Fig S14C), consistent with a role for PPAR in mito-
chondrial metabolism (Zhang et al, 2015). Further analysis of RNA
in tesaglitazar-injected sperm confirmed significant GO term
enrichments for fatty acid and lipid biosynthetic and metabolic
processes (Fig 4E), pathways relevant for PPAR activity. Together,
these data suggest a link between PPAR pathways in the periphery
and long-term effects on sperm RNA.
Serum upregulates PPAR activity in spermatogonial stem
cell-like cells
RNA in sperm is thought to originate in part from earlier stages of
spermatogenesis (Gapp et al, 2020), since mature sperm cells them-
selves are transcriptionally silent. Interestingly, sperm long RNA
was not altered by tesaglitazar 1 day after the final injection unlike
46 days following the last injection (Appendix Fig S15A–D). This
suggests that sperm cells are not directly affected (at least not at the
level of RNA) and thus that the drug may induce changes at earlier
spermatogenic stages that only appear later in mature sperm. To
confirm this hypothesis, we assayed PPAR activity in GC-1 spg cells
carrying a PPRE reporter exposed to serum collected 1 day after
tesaglitazar injection and observed increased luminescence
compared to cells exposed to serum from vehicle-injected controls
(Appendix Fig S16). These results indicate that serum from both
MSUS and tesaglitazar-injected males can upregulate PPAR activity
directly in early-stage spermatogenic cells. Indirect effects of PPAR
activation mediated by secondary factors present in circulation may,
however, also occur in vivo. But this is unlikely the case with
tesaglitazar since circulating metabolites are not affected by drug
treatment, suggesting that there are no secondary factors at the time
of breeding (Appendix Fig S17).
In vivo serum transfer induces phenotype transmission
to offspring
We next tested if serum can also have effects in vivo. Blood was
collected from 4-month-old MSUS and control males, and serum
was prepared and chronically injected intravenously (i.v.) in control
adult males (Fig 5A). We chose serum over plasma for in vivo injec-
tions to avoid potential interference of clotting factors. Following 4-
week treatment, males were bred with control females to generate
offspring that were phenotyped when adult. The offspring of males
injected with MSUS serum trended towards reduced weight (Fig 5B)
and had significantly decreased blood glucose upon acute stress
(Fig 5D), similar to that observed in MSUS offspring (Fig 5B and C,
Gapp et al, 2014a). There was no difference in blood glucose on
GTT in these offspring (Appendix Fig S11B), like in MSUS mice
(Gapp et al, 2014a). The results indicate that the metabolic effects
of MSUS serum are different from those of tesaglitazar treatment,
which is expected since MSUS is a complex paradigm that activates
components of the stress response, such as hormones, non-lipid
metabolites and other circulating and cellular constituents. To
assess whether other factors than metabolites are involved, we
examined proteins in plasma using unbiased mass spectrometry. No
significant difference passing multiple testing corrections could be
detected (Appendix Fig S18A). One interesting candidate was C-
reactive protein (CRP), which was downregulated in the proteomic
datasets and could be confirmed by ELISA in a separate batch of
MSUS samples (Appendix Fig S18B). CRP is a marker of inflamma-
tion linked to PPAR signalling and can be negatively regulated by
PPAR activity (Zambon et al, 2006). We also examined RNA in
serum since circulating miRNAs are known to communicate with
tissues outside their site of origin (Thomou et al, 2017), and
because RNA itself has been implicated in epigenetic inheritance
(Rassoulzadegan et al, 2006; Gapp et al, 2014a; Grandjean et al,
2016). No significant difference in small RNAs could be detected in
MSUS serum after multiple testing correction (Appendix Fig S19).
These results suggest that circulating miRNAs probably do not play
a major role, although exosomal or HDL-associated RNA uptake
(Cossetti et al, 2014) cannot be excluded. It should be noted that
individual miRNAs were previously found by qPCR to be altered in
MSUS serum (Gapp et al, 2014a) but this discrepancy may be due to
technical differences in serum preparation or in RNA detection
between RNA sequencing and qPCR.
Discussion
Germ cells are the carrier of biological heredity that passes informa-
tion from parent to progeny, information that is now recognized to
◀
Figure 4. Differential RNA payloads in sperm from tesaglitazar-injected males and overlap with sperm from MSUS males.
A, B Differentially expressed (A) transposable elements and (B) mRNAs/lincRNAs in sperm from Tesa-inj and MSUS males. Data represent genes with P < 0.05 and
similar fold change. Fold change in heat map represents log2(fold change) respective to the corresponding control group. Total overlap is presented in Appendix
Fig S13.
C, D (C) Volcano plot and (D) heat map of differentially expressed (FDR < 0.05) mRNA/lincRNA in sperm from Tesa-inj males. Dashed black lines in (C) represent y = 1.3,
equivalent to FDR = 0.05, and x = 0.03, equivalent to FC = 1.23 and 0.81. Black dots represent top candidates, which all have FC > 2 or FC < 0.5, and FDR < 0.05.
Teal dots represent non-significant genes.
E GO enrichment scores for differential RNA in Tesa-inj male sperm. Enrichments calculated with P < 0.05. For Tesa-inj, n = 6; Vehicle-inj, n = 7; MSUS, n = 4; and
control, n = 3. Dashed black line represents FDR = 0.05. FDR, false discovery rate; FC, fold change.
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involve both the genome and the epigenome (Chen et al, 2016).
Because germ cells are sensitive to environmental factors, especially
in early life (Day et al, 2016), they are subjected to alterations by
exposure. If these alterations persist and are present at the time of
conception, they may be transferred to the offspring. Our results
(Appendix Fig S20) newly identify circulating factors as causal
mediators of metabolic effects of postnatal trauma from exposed
father to the offspring and highlight PPAR as one of the molecular
contributors. While stress activates the sympathetic nervous system
and the hypothalamic–pituitary–adrenal (HPA) axis, our results
show that lipid metabolism also plays a role in the response of the
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(Carone et al, 2010; Zeybel et al, 2012; Chamorro-Garcia et al,
2017). This may have important implications for the clinic since
metabolic syndrome is a common co-morbidity in the sequela of
childhood trauma (Suglia et al, 2018). The results also provide a
novel link between PPAR and germ cells, and a possible biological
role for the known property of transcription factors to poise tran-
scriptional states in gametes and influence the developmental trajec-
tory of zygotes (Jung et al, 2017). The additional correlation
between PPAR activation and MSUS-induced TE dysregulation in
sperm further points towards potential consequences on epigenetic
control of TE-coregulated genes in the embryo (Sharma et al, 2016).
PPAR pathways in germ cells may thus contribute to differential
gene expression previously observed in MSUS offspring at zygotic
stage (Gapp et al, 2020). Serum factors may also act in part via
somatic cells in gonads such as Sertoli, Leydig or epididymal cells
which have direct contact with germ cells (Sæther et al, 2007;
Sharma et al, 2016). Although the contribution of such intermediate
cellular signals between circulation and germ cells cannot be ruled
out, our results indicate that factors in serum are sufficient to induce
the transmission of phenotypes to the offspring. The contribution of
extracellular vesicles to the distribution of altered metabolites or
additional factors such as RNA relevant for transmission has not
been assessed but could present another potential vector for infor-
mation transfer. Other mechanisms involving epigenetic processes,
already implicated in phenotype transmission in several models
including MSUS (Franklin et al, 2010; Gapp et al, 2014b), may also
operate. It would be interesting in the future to conduct metabo-
lomic profiling in other inter- or transgenerational models and in
other body fluids such as lymph or seminal fluid (Di Venere et al,
2018) to clarify the role of such pathways in transmission. Moderate
alterations in single metabolites are unlikely to induce transmission
of the observed phenotypes on their own, yet it might be interesting
to evaluate whether a large excess of individual metabolites and
activation of target receptors could induce a phenotype in the
offspring. Notably, our results suggest beneficial effects of tesagli-
tazar on offspring metabolism as reported earlier (Wallenius et al,
2013), which is consistent with the known therapeutic benefit of
PUFA supplementation (Huber et al, 2007; Braarud et al, 2018). The
timing and duration of PPAR activation may also be further opti-
mized to elicit differential effects.
Finally, these findings bring new fundamental knowledge about
the influence of the environment on the germline by extending the
notion of non-DNA based inheritance, known to involve epigenetic




C57Bl/6J mice were kept under a 12-h reverse light/dark cycle in a
temperature- and humidity-controlled facility. Animals had access to
food and water ad libitum. Experimental procedures were performed
during the animals’ active cycle (reverse light cycle in the facility,
light on at 9 am and off at 9 pm) in accordance with guidelines and
regulations of the Cantonal Veterinary Office, Zürich, except for those
involving serum-injected mice and their offspring that were
performed during the animals’ inactive cycle as approved by the
Home Office, United Kingdom. Animal licences covering this work
have the number: 57/15 and 83/18 cover the conducted experiments.
Msus
To obtain MSUS mice, 3-month-old C57Bl/6J primiparous females
were paired with age-matched control males for 1 week; 40 breed-
ing pairs were used. After birth of pups, dams were randomly
assigned to MSUS or control groups, in a way to balance litter size
and number of animals across groups. Dams assigned to MSUS
group were separated from their pups for 3 h per day unpredictably
from postnatal day (PND) 1 to 14. Separation onset was at an unpre-
dictable time within the 3 h, and during separation, each mother
was randomly exposed to an acute swim in cold water (18°C for
5 min) or 20-min restraint in a tube. Control animals were undis-
turbed apart from cage changes once per week (like MSUS). At
PND21, pups were weaned from their mother and assigned to cages
in groups of 3–5 mice/cage housed by gender and treatment.
Siblings were distributed in different cages and mixed with pups
from different mothers to avoid litter effects. Total number of
fathers and offspring for each experiment is provided in
Appendix Fig S21.
Metabolomic measurements
Metabolites were extracted from 10 ll plasma 3 times with 70%
ethanol at a temperature > 70°C. Extracts were analysed using flow
injection–time-of-flight mass spectrometry (Agilent 6550 QTOF)
operated in negative mode, as described previously (Fuhrer et al,
2011). Distinct mass-to-charge (m/z) ratio could be identified in
each batch of samples (typically with 5,000–12,000 ions). Ions were
annotated by aligning their measured mass to compounds defined
by the KEGG database, allowing a tolerance of 0.001 Da. Only
◀
Figure 5. Injection of serum from MSUS mice recapitulates some MSUS metabolic phenotypes in the offspring.
A Serum was injected (90 ll) twice per week for 4 weeks into age-matched control males. After injection, the males were paired with control females and their
offspring were phenotyped when 3 months old and compared to the offspring of MSUS males.
B Weight in adult male MSUS offspring and the offspring of males injected with MSUS serum compared to respective control groups. MSUS offspring, n = 22; control
offspring, n = 24, one-tailed Student’s t-test (data reproduced) P = 0.045, t = 1.734, df = 44. MSUS serum-injected offspring, n = 30; control serum-injected
offspring, n = 31, two-tailed Mann–Whitney U = 334.5, P = 0.059.
C, D Blood glucose levels in MSUS offspring and the offspring of MSUS serum-injected males following a 30-min restraint challenge. MSUS offspring, n = 13; control
offspring, n = 12, repeat-measures ANOVA, treatment effect P = 0.016, F (1, 23) = 6.704, time effect P < 0.0001, F (3, 69) = 53.13, interaction P = 0.027, F (3,
69) = 3.25, at 15 min adjusted P = 0.0015, t = 3.693, df = 92. MSUS serum-injected offspring, n = 17; and control serum-injected offspring, n = 14, repeat-
measures ANOVA, treatment effect P = 0.023, F (1,14) = 6.493, time effect P < 0.0001, F (3, 42) = 48.4, interaction P = 0.29, F (3, 42) = 1.29. Conc., concentration.
Data information: Data are reported as mean  SEM.
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deprotonated ions (without adducts) were considered in the analy-
sis. When multiple matches were identified, such as in the case of
structural isomers, all candidates were retained. For enrichment
analysis, metabolites with P < 0.05 and log2(fold change) > 0.25
or < 0.25 follow a previously described procedure (Subramanian
et al, 2005). Enrichments were considered significant when
FDR < 0.05 after multiple testing corrections using the Benjamini–
Hochberg post hoc test.
Blood and tissue collection
Mouse pup siblings at postnatal day 8 (after 7 days of MSUS treat-
ment) were sacrificed from each cage after removing the mother,
and all pups (up to 10) were sacrificed within 2 min. For blood and
tissue collection in adults, males were singly housed overnight with
food and water to avoid activating their stress response by the
successive removal of littermates. Details of serum/plasma process-
ing are described in different sections of the methods.
Blood collection for metabolomic and proteomic analyses
Trunk blood was collected in EDTA-coated tubes (Microvette, Sarst-
edt) from PND8 pups (5 control and 5 MSUS, from different litters)
and 4-month-old (for MSUS offspring, 5 control and 5 MSUS, from
different litters) or from 6-month-old (for MSUS adults, 5 control
and 5 MSUS, from different litters) mice after decapitation. Samples
were stored at 4°C for 1–3 h and centrifuged at 2,000 × g for
10 min. Plasma was collected and stored at 80°C until processed
for analysis. For analyses, samples from pups from different litters
(and not from siblings) or from adult mice from different cages (and
not cage mates) were chosen.
Sperm collection
Sperm was collected using a swim-up method as described previously
(Brykczynska et al, 2010). Briefly, cauda epididymis was dissected
and perforated with dissection scissors and placed in M2 medium
(Sigma-Aldrich) for 1 h to allow mature sperm to swim out of the
tissue. Medium was collected and spun down at 2,000 × g for 6 min at
4°C. Sperm pellets were then resuspended in 15 ml somatic cell lysis
buffer (contains 1% SDS (10%) and 0.5% Triton X-100 in Milli-Q
water) and left to incubate on ice for 10 min. Sperm was re-pelleted by
centrifugation at 2,000 × g for 6 min at 4°C and washed twice with ice-
cold PBS (spun after each wash at 2,000 × g for 6 min at 4°C). After the
final wash, an aliquot of sperm was used for counting (Appendix Fig
S22) and then pellets were stored at80°C until further use.
Tissue collection
Following decapitation and blood collection, mice were pinned by
their feet to a sterilized dissection board. A midline incision was
made from the subcostal region to the pubic zone where two trans-
verse incisions were made bilaterally to the femur, exposing internal
organs. Biopsies from white adipose tissue were collected proximal
to the epididymis on each side.
Aldosterone enzyme-linked immunosorbent assay (ELISA)
Aldosterone concentration in serum was measured using a competi-
tive ELISA (Abnova, KA1883) according to the manufacturer’s
protocol. 50 ll of standards, control and serum samples from adult
MSUS and control males was added to wells containing aldosterone
antibody, and an HRP-conjugated aldosterone antigen was added.
After 1-h incubation at room temperature for competitive binding,
cells were washed and tetramethylbenzidine (TMB) substrate was
added for colour development, followed by addition of stop solu-
tion. Absorbance was measured at 450 nm with a NOVOstar
Plate Reader (BMG Labtech), and sample absorbance (inversely
related to concentration) was determined by plotting a standard
curve with manufacturer-supplied standards and controls. Samples
were measured in duplicate and averaged.
Human cohort
To assemble a cohort of children exposed to trauma, we contacted
the administration of SOS Children’s Village in Lahore, Pakistan,
and selected children using the following criteria at the time of
assessment: (i) age between 6 and 12 years, (ii) paternal death, (iii)
maternal separation in the form of adoption by the SOS village and
(iv) entry of the child to the SOS village within 12 months preceding
the assessment. Maternal separation was forced because mothers
could no longer provide sufficient support to their child and had to
transfer their care to the SOS village. They had no or minimal
contact with their child at the time of assessment. Maternal suffering
during childhood and early adolescence is known to affect mental
health in adulthood (Abel et al, 2014). Paternal loss was used as an
inclusion criteria, because spousal death is a critical life stressor in
human (Prior et al, 2018), and serves to mimic unpredictable mater-
nal stress of the MSUS model. Exclusion criteria included: (i) history
of abuse and (ii) history of traumatic brain injury, intellectual
disability or cerebral palsy. Based on these criteria, a total of 26 chil-
dren with paternal loss and maternal separation (PLMS) were
selected. A control group (n = 16) was recruited among school-
mates of PLMS children and comprised 6- to 12-year-old children
living with both parents and having no history of trauma, traumatic
brain injury, intellectual disability or cerebral palsy. Complete confi-
dentiality of participants was maintained at all stages of data collec-
tion and analyses. The administration of the SOS village, Lahore,
Pakistan, was informed and approved all study procedures.
Demographics
Detailed demographic information for PLMS and control groups was
provided by the administration of the SOS village for the PLMS chil-
dren and from parents for control children. This included age,
gender, parental consanguinity (defined by 1st or 2nd cousin parental
union) and physical health records. Weight and height were
measured in all children by two research interns blinded to the
study design. Children were classified as underweight, healthy
weight or overweight based on their correspondence to the “less
than 5th percentile”, “between 5th and 85th percentile” and “85th to
95th percentile” reference ranges defined for Pakistani children of
the same age and sex (Mushtaq et al, 2012).
Serum and saliva sample collection
Blood was collected by a trained phlebotomist blinded to the study
design. Blood withdrawal took place during the morning school
hours for both groups approximately 1 h after their last oral intake.
All children received a brief explanation of the blood withdrawal
procedure and were promised a gift basket for their cooperation.
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Children showing reluctance or despair were excluded (6 PLMS and 2
controls). After sterilization with a swab, axillary vein venepuncture
was performed through a butterfly syringe and 6 ml blood was
collected per child in serum separating tube (BD Vacutainer, Thermo
Fisher scientific). After 1-h incubation at room temperature, the tubes
were centrifuged at 1,300 × g for 10 min at 4°C for serum separation.
Extracted serum was aliquoted into 1.5-ml tubes and stored at 80°C.
Saliva was collected by two research interns blinded to the study
design. Children who had active upper respiratory tract infections
(identified through the symptoms of fever, rhinorrhoea or cough) at
the time of sample collection were excluded (1 PLMS and 2 controls).
All children received a brief explanation of the saliva collection proce-
dure and were promised a gift basket for their cooperation. After a 1-
h period of no oral intake, the children were asked to rinse their
mouth with clear water twice. Saliva was collected 5 min after rinsing
through passive drooling in salivette tubes (Sarstedt) over a period of
5 min. Collected saliva was aliquoted into 1.5-ml tubes and stored at
80°C. Serum and saliva aliquots were shipped to Zürich in packages
containing 20 kg of dry ice for analysis.
Luciferase assay in GC-1 spg cells
GC-1 spg cells were obtained from ATCC (ATCC CRL-2053TM) and
cultured at 37°C in Dulbecco’s modified Eagle’s medium (DMEM—
high glucose, Sigma-Aldrich) supplemented with 10% (v/v) foetal
bovine serum (FBS, HyClone) and 40 lg/ml gentamicin (Sigma-
Aldrich). Cells were passaged 1:10 every 3–4 days for 3 passages
before being transfected. Prior to transfection, 4,000 cells were
plated per well in 48-well plates. Cells were co-transfected with
PPRE X3-TK-luc plasmid, expressing firefly luciferase, and pRL-
SV40P plasmid, expressing Renilla luciferase, using Lipofectamine
2000 Reagent (Thermo Fisher Scientific), according to the manufac-
turer’s protocol. PPRE X3-TK-luc was a gift from Bruce Spiegelman
(Kim et al, 1998) (Addgene plasmid #1015; http://n2t.net/addgene:
1015; RRID:Addgene_1015), and pRL-SV40P was a gift from Ron
Prywes (Chen & Prywes, 1999) (Addgene plasmid #27163, RRID:
Addgene_27163). Plasmid DNA and Lipofectamine reagent were
mixed in the supplied OptiMEM and added to culture medium such
that each well received 200 ng plasmid DNA and 0.5 ll Lipofec-
tamine. Following 24 h, transfection medium was replaced with
control or MSUS serum-enriched medium. Serum was added to
culture medium at 10% (v/v) and then sterile-filtered using 0.22-lm
PVDF filter units (Merck) before being dispensed into individual
wells. Each cell sample was treated with serum collected from an
individual adult male. Luciferase signal produced from firefly and
Renilla reporter plasmids was measured using the Dual Reporter
Luciferase Assay System (Promega) with a GloMAX Multi Detection
System (Promega). For each sample, firefly luminescence was
normalized to the stable Renilla luminescence signal coming from
the same well. Firefly and Renilla luminescence signals were absent
in non-transfected cells (Appendix Fig S23).
RT–qPCR
For gene expression analyses in sperm and liver, RNA was extracted
using a phenol/chloroform extraction method (TRIzol; Thermo
Fisher Scientific). Reverse transcription was performed on purified
RNA samples with miScript II RT reagents (Qiagen) using HiFlex
buffer. RT–qPCR was performed with QuantiTect SYBR (Qiagen) on
a Light Cycler II 480 (Roche). All samples were run in triplicate
under the following cycling conditions: 95°C for 15 min, 45 cycles
of 15 s at 94°C, 30 s at 55°C and 30 s at 70°C, followed by melt
curve with gradual temperature increase until temperature reached
95°C. Melt curve analysis confirmed amplification of single products
for each primer. The endogenous control TUBD1 for sperm, and
RPLP0 for liver, was used for normalization. Primer sequences are
proprietary (Qiagen). Expression levels were analysed with two-
tailed Student’s t-test.
PPARc transcription factor binding assay
PPARc transcription factor binding activity was measured in nuclear
extracts from epididymal white adipose tissue (eWAT). Nuclear
proteins were collected from 10 mg eWAT using a Nuclear Extrac-
tion Kit (Abcam, ab113474). Protein concentration in nuclear
extracts was measured using Qubit Protein Assay Kit (Thermo
Fisher Scientific), and volumes were adjusted to have similar
protein concentration across samples. PPARc binding activity was
measured using a PPARc Transcription Factor Assay Kit (Abcam,
ab133101) following the manufacturer’s protocol. Briefly, 10 ll of
nuclear extracts was added with binding buffer to individual wells
of a plate conjugated with DNA sequences containing known PPARc
binding motifs and incubated at 4°C overnight. Wells were washed
5× with wash buffer, and primary antibody against PPARc was
added for 1 h at room temperature without agitation. Wells were
washed again 5× with wash buffer, and an HRP-containing
secondary antibody was added to wells and incubated at room
temperature for 1 h. Following another 5× wash, a developing solu-
tion was added and incubated under gentle agitation for 45 min.
The reaction was stopped by adding stop buffer, and absorbance
was measured immediately with NOVOstar Plate Reader (BMG
Labtech). Samples were measured in duplicate, alongside a positive
control supplied by the manufacturer to confirm assay success. Data
were analysed with two-tailed Student’s t-test.
Drug injections
Tesaglitazar
Three-month-old mice were injected i.p. with either tesaglitazar
solution at 10 lg per kg body weight or vehicle control twice per
week for 4 weeks. Tesaglitazar (Sigma-Aldrich) was solubilized in
DMSO at 10 lg per ll and resuspended in sterile 0.9% saline. Vehi-
cle consisted of equivalent DMSO in 0.9% sterile saline. Mice were
weighed at baseline, before each injection and 6 weeks after the last
injection. Males were paired with 3-month-old primiparous control
females 46 days after the last injection. Pairing lasted 1 week; then,
males were grouped back with their original littermates. After pair-
ing, females were separated into individual cages until delivery. The
offspring were reared in standard conditions, with one cage change
per week, and were weaned at PND21 in social groups (3–4/cage)
with pups from other litters to avoid litter effects. When 3 months
old, offspring were subjected to phenotyping.
T0070907
3-month-old control and MSUS males were injected with either vehi-
cle control or 1.5 mg per kg T0070907 once per week for 2 weeks.
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T0070907 was solubilized in DMSO at 10 lg per ll and resuspended
in 0.9% saline; vehicle control consisted of 0.9% saline with equiva-
lent DMSO concentration. Mice were paired with females 1 day after
the final injection. Pairing lasted 1 week; then, males were placed
back in cages with original littermates. After pairing, females were
separated into individual cages until delivery. The offspring were
reared in standard conditions, with one cage change per week, and
were weaned at PND21 in social groups (3–4/cage) with pups from
other litters to avoid litter effects. When 3 months old, offspring
were subjected to phenotyping.
Metabolic testing
Before testing, cages were labelled such that the experimenter was
blind to treatment group. When more than one experimenter was
required to conduct a given test, each experimenter tested a similar
number of control and MSUS animals to exclude experimenter-
specific effects. Control and MSUS treatment groups were tested
alternately or side by side to avoid circadian effects (in a blinded
manner for the experimenter). All glucose measurements were
performed using fresh blood droplets with an Accu-Chek Aviva
glucometer (Roche).
Glucose in response to restraint
Mice were single-housed for minimum 4 h but no more than 18 h
prior to testing with access to food and water. For physical restraint,
each mouse was confined individually in a cylindrical plastic tube
(3.18 cm diameter with sliding nose restraint, Midsci) for 30 min.
Blood was drawn at 0, 15, 30 and 90 min after initiation of restraint
using a 28-G needle to prick the tail from within 1 cm of the tip.
After blood was collected at the 30-min time point, each mouse was
released and placed in an individual temporary cage. At 90 min, the
mouse was briefly (10 s) placed under an inverted 1-litre glass
beaker (dimensions: 14.5 cm high and 12 cm diameter) with its tail
positioned to protrude from the beaker spout for easy access by the
experimenter. The mouse was then placed back into its temporary
cage for 1 h and then returned to its original group cage. Data were
analysed with repeated-measures ANOVA and corrected for multiple
comparisons using Sidák post hoc test.
Glucose tolerance test
Mice were singly housed without food starting between 5 and 6 pm,
and testing began at 9am the next morning. Glucose was measured
in blood samples at 0, 15, 30, 90 and 120 min following intraperi-
toneal (i.p.) injection of sterile glucose solution containing 2 mg per
g of body weight in 0.45% (wt/vol) saline. Each mouse was kept
under an inverted 1-litre beaker with its tail in the spout as
described above. After taking the 30-min measurement, each mouse
was placed in an individual cage and then taken again out briefly
(10 s) for measurements at 90- and 120-min time point. The mouse
was placed back into its temporary cage for 1 h before returning to
its original group cage, to reduce fighting due to experimental stress.
Data were analysed with repeat-measures ANOVA and corrected for
multiple comparisons using Sidák post hoc test.
Food intake and weight measurement
All animals were weighed using the same scale at the same time of
day. Following weight measurements, food intake was also
measured. Food pellets were weighed at the beginning and end of
three consecutive days and replaced every 24 h to limit crumb spil-
lage. Food consumption was calculated per cage (maximum 5
animals) and averaged per animal. No difference in food intake was
observed. Data were analysed with two-tailed Student’s t-test,
except for MSUS offspring, which was analysed with one-tailed
Student’s t-test to confirm previous reports (Gapp et al, 2014a).
RNA sequencing
RNA was extracted from sperm using the TRIzol/chloroform
method and analysed using Bioanalyzer (Agilent 2100). Sequencing
was performed using Illumina Genome Analyzer. RNA libraries
were prepared with the TruSeq Small RNA and TruSeq Stranded
Total RNA kits according to the manufacturer’s instructions with
the following modifications: 1:3 for sperm long RNA. Serum small
RNA was amplified for a total of 16 cycles, and sperm long RNA
was amplified for a total of 15 cycles. 220 ng total sperm RNA was
depleted of rRNAs using Ribo-Zero Gold and further processed in
RNA libraries. High-throughput sequencing was performed on a
Genome Analyzer HiSeq 2500 (Sanger Institute, Cambridge) for 36
and 51 cycles for 50 bp and 100 bp runs, respectively, plus 7 cycles
to read the indexes. Serum small RNA libraries were run twice, and
data were merged. For library preparation of sperm RNA collected
from males 24 h after tesaglitazar injection, a slightly different
protocol was used. The quality of the isolated RNA was determined
with a Qubit (1.0) Fluorometer (Life Technologies, California,
USA) and a Fragment Analyzer (Agilent, Santa Clara, California,
USA). TruSeq Stranded mRNA kit (Illumina, Inc, California, USA)
was used to prepare libraries. Briefly, total RNA (300 ng per
sample) was polyA-enriched and then reverse-transcribed into
double-stranded cDNA. The cDNA was fragmented, end-repaired
and adenylated before ligation with TruSeq adapters containing
unique dual indices (UDI) for multiplexing. Fragments containing
TruSeq adapters on both ends were selectively enriched by PCR.
The quality and quantity of enriched libraries were validated using
Qubit (1.0) Fluorometer and Fragment Analyzer (Agilent, Santa
Clara, California, USA). The product is a smear with an average
fragment size of approximately 260 bp. The libraries were normal-
ized to 10 nM in Tris–Cl 10 mM, pH 8.5, with 0.1% Tween-20; then,
NovaSeq 6000 (Illumina, Inc, California, USA) was used for cluster
generation and sequencing according to a standard protocol.
Sequencing was paired end at 2 × 150 bp or single end at 100 bp.
Long RNA-sequencing analysis
Single-end reads were assessed for quality using FastQC (version
0.11.5) (Andrews, 2010). Quality control was performed with Trim
Galore (version 1.16) (Krueger, 2012), and bases with quality score
< 30 (-q 30) and reads shorter than 30 bp were also removed (–
length 30), and adapters were removed. Filtered reads were pseudo-
aligned with Salmon (version 0.11.2) (Patro et al, 2017) with
library-type parameter (-l SR), on a transcriptome index prepared
with (i) the GENCODE (Frankish et al, 2019) annotation (version
M18), (ii) piRNA precursors (Li et al, 2013) and (iii) transposable
elements (TEs) from repeat masker (concatenated by family). For
differential expression analysis, normalization factors were calcu-
lated using the TMM method (Robinson & Oshlack, 2010) on all
quantified RNAs aggregated at the gene (or repeat element family)
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level, and repeat elements or mRNA and lincRNAs were selected for
testing. Only features with more than 20 reads in at least a number
of samples equivalent to 80% of the size of the smallest experimen-
tal group were considered. In the case of MSUS sperm, where two
libraries per sample were available, the voom/dupCor method of
the limma R package v.3.34.9 (Ritchie et al, 2015) was used as
previously (Gapp et al, 2020) to account for non-independence of
the samples. In all other cases, edgeR v.3.24.0 was used with the
exact test. Concordance between datasets was estimated through a
Pearson correlation of fold change of genes with P < 0.05 in both
datasets. Gene Ontology (GO) enrichment analysis was performed
using the goseq R package (Young et al, 2010) (Fisher’s exact test).
This accounts for length bias in RNA-seq experiments using GO
terms with 10–1,000 annotated genes. Only genes with existing GO
annotations were used. Only differentially expressed genes
subjected to count filtering were used as background for enrichment
analysis. Since duplication can be attributed to biological variations,
duplicates were not removed from the analyses.
Short RNA-sequencing analysis
RNA-seq reads were trimmed of adapter sequences using cutadapt
v1.14 with a 5% error rate and collapsed to unique sequences
before being aligned on a custom genome containing, in addition to
normal contigs, DNA sequences of spliced post-transcriptionally
modified RNAs (such as tRNAs) obtained from GtRNAdb 2.0 data-
base. Reads were first aligned using bowtie1 end-to-end alignment
without mismatch (and accepting -m 1000), and remaining reads
were aligned allowing soft clipping and a mismatch. Reads overlap-
ping with known features (including miRBase miRNAs, GENCODE
and RepeatMasker features, and piRNA precursors) were counted,
resolving multiple alignments through a hierarchy of features (for
instance, reads mapping to multiple tRNA genes of the same family
were assigned to the family). Normalization factors were calculated
over ll identified features using the TMM method, and differential
expression was performed at all levels of the feature hierarchy.
Serum sampling and intravenous injection
Four-month-old MSUS and control males were sacrificed by decapi-
tation, and trunk blood was collected in non-coated Eppendorf tubes
and clotted overnight at 4°C. After centrifugation for 10 min at
2,000 × g at 4°C, serum was collected and stored at 80°C. When
2 months old, control mice received 8 tail vein injections of 90 ll of
serum from adult MSUS or control mice over the course of 4 weeks
(twice/week). For each group, serum from 43 mice was pooled
before injections to obtain sufficient volume for all injections. For
injections, mice were placed in a tube in a heating chamber at 38°C.
Injections were alternated between opposing lateral veins of the tail.
Proper insertion of the injection needle was successful on the first
attempt in most cases and never took more than 3 attempts. Each
male was paired with a primiparous adult control female 12 days
after the last injection for 1 week.
Proteomic measurements
Plasma samples were enriched for small regulatory proteins using
protein depletion columns (Seppro Mouse, Sigma-Aldrich) and
quantified using a Qubit Protein Assay Kit (Thermo Fisher
Scientific). Samples were purified by TCA precipitation and
processed with a filter-assisted sample preparation (FASP) protocol.
First, 20 lg of protein was resuspended in 30 ll SDS denaturation
buffer (4% SDS (w/v), 100 mM Tris–HCl, pH 8.2, 0.1 M DTT) and
incubated at 95°C for 5 min. Then, samples were diluted with
200 ll UA buffer (8 M urea, 100 mM Tris–HCl, pH 8.2) and spun at
35°C at 14,000 × g for 20 min in regenerated cellulose centrifugal fil-
ter units (Microcon 30, Merck Millipore). Samples were washed
once with 200 ll of UA buffer and spun again at 35 °C and 14,000 ×
g for 20 min. Cysteines were blocked with 100 ll IAA solution
(0.05 M iodoacetamide in UA buffer) and incubated for 1 min at RT
in a thermomixer at 600 rpm followed by 14,000 × g centrifugation
at 35°C for 15 min. Filter units were washed 3× with 100 ll of UA
buffer and then 2× with a 0.5 M NaCl solution in water. Each wash
step was followed by 14,000 × g centrifugation at 35°C for 15 min.
Proteins were digested overnight at room temperature with 1:50
ratio of trypsin (0.4 lg) in 130 ll TEAB (0.05 M triethylammonium
bicarbonate in water). After digestion, peptide solutions were spun
down at 35°C and 14,000 × g for 15 min and acidified with 3 ll of
20% TFA (trifluoroacetic acid). Peptides were cleaned using Sep-
Pak C18 silica columns (Waters Corporation) activated with 1 ml
methanol and washed with a solution 1 ml of 60% ACN (acetoni-
trile) and 0.1% TFA. Columns were equilibrated with 3 × 1 ml of
3% ACN 0,1% TFA. The samples were diluted in 800 ll of 3% ACN
0.1% TFA and loaded onto the silica columns, then washed with
4 × 1 ml 3% ACN 0.1% TFA and eluted with 60% ACN 0.1% TFA.
Samples were lyophilized in a SpeedVac and re-solubilized in 19 ll
3% ACN 0.1% FA (formic acid). 1 ll of synthetic peptides (Biog-
nosys AG) was added to each sample for retention time calibration.
Peptides were analysed by LC-MS/MS (Orbitrap FusionTM TribidTM
MS, Functional Genomics Center Zürich). Samples were random-
ized, and group identities were unknown during measurements to
blind the experimenter. Raw data were quantitatively and qualita-
tively analysed by Mascot and Progenesis QI platforms.
C-reactive protein (CRP) ELISA
CRP concentration in serum was measured using a quantitative
sandwich ELISA (Abcam, ab157712) according to the manufac-
turer’s protocol. Briefly, 100 ll of standards, control and serum
samples (diluted 1:10 (v/v) in supplied diluent) from adult MSUS
and control males were added to wells containing anti-CRP. Then,
HRP-conjugated anti-CRP antibodies were added. After 10 min of
incubation at room temperature, wells were washed and then
exposed to the chromogenic substrate tetramethylbenzidine (TMB)
for 5 min in the dark at room temperature; then, a stop solution
was added to each well. Absorbance was measured at 450 nm with
a NOVOstar Plate Reader (BMG Labtech), and sample absorbance
(directly related to concentration) was determined by plotting a
standard curve with manufacturer-supplied standards and controls.
Concentrations were analysed with one-tailed Student’s t-test for
mouse samples (as validation of proteomic data).
Statistical analysis
Samples size was estimated based on our previous work with the
MSUS model (Franklin et al, 2010, 2011; Gapp et al, 2014a,b,
2016a,b; Bohacek et al, 2015). Bodyweight, GC-1 spg luciferase
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luminescence and PPARc transcription factor binding assay were
assessed using two-tailed Student’s t-tests. CRP and aldosterone
ELISA measurements were assessed using one-tailed Student’s t-test
since they were validation of proteomic and metabolomic datasets.
For some phenotyping experiments, the data presented were repro-
duced from previously published findings, in which case one-tailed
tests were used. In all such cases, this is clearly stated in the text.
Glucose tolerance tests and glucose in response to restraint chal-
lenge were analysed using repeat-measures ANOVA and corrected
for multiple comparisons using Sidák post hoc test. Most data
matched the requirements for parametric statistical tests (normal
distribution and homogeneity of variance). For data not normally
distributed, Mann–Whitney U-test was used. This was the case for
serum-injected offspring weight measurements, PLMS depression
scale and PLMS age. Outliers were determined using the pre-defined
criteria of adding and subtracting twice the standard deviation from
the mean. Reported n represents number of animals after outlier
removal. Whenever possible, re-analyses of data with n as litters
instead of individual mice were conducted and confirmed the
effects. Use of n as litters was considered but not implemented due
to limited mouse numbers authorized by the animal license.
Animals were randomly distributed to control and treatment groups
prior to the experiments and before any contact with the experi-
menters. For individual metabolites and metabolomics enrichments,
FDR was calculated using Benjamini–Hochberg (BH) post hoc test.
Statistics were mainly computed with GraphPad Prism unless stated
otherwise. Reported n for metabolomics represents biological repli-
cates. Error bars represent s.e.m. in all figures. For all data, signifi-
cance was set at a minimum P < 0.05. For a trend, #P < 0.1.
Asterisks represent significance as follows, *P < 0.05, **P < 0.01,
***P < 0.001 and ****P < 0.0001. Type of analysis and descriptive
data for each statistical test are presented in figure legends.
Data availability
The datasets collected in this study are available in the following
databases:
• RNA-sequencing data: Gene Expression Omnibus GSE154369
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE1543
69)
• Raw data: ETH research collection 20.500.11850/426674
(https://doi.org/20.500.11850/426674)
• Proteomics data: ETH research collection 20.500.11850/426674
(https://doi.org/20.500.11850/426674)
• Metabolomics data: ETH research collection 20.500.11850/426674
(https://doi.org/20.500.11850/426674)
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